CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
40 hedge funds and large institutions have $13.5M invested in Carisma Therapeutics in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 36 → 40 (+4)
0.08% more ownership
Funds ownership: 0.77% → 0.85% (+0.08%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
40
Holding in Top 10
1
Calls
$183K
Puts
$15K
Top Buyers
| 1 | +$770K | |
| 2 | +$504K | |
| 3 | +$365K | |
| 4 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
+$145K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$80K |
Top Sellers
| 1 | -$482K | |
| 2 | -$178K | |
| 3 | -$29.1K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$23K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$11.4K |